Introduction
Oligopeptidase B (OpdB, E.C. 3.4.21.83 ) is a proteolytic enzyme that belongs to the prolyl oligopeptidase family (POP) of serine proteases [10, 24] . Initially discovered in E. coli, this enzyme was found in several gram-negative bacteria, spirochetes, [6, 24] , and protozoa [5, 14] , but not in higher eukaryotes, with the exception of some plants [6] . Although the physiological role of OpdB has not yet been elucidated in bacteria, it has been recently recognized as an important virulence factor in trypanosome infections [17, 18] . In particular, in infective forms of Trypanosoma cruzi, OpdB generates a calcium signalling factor that interacts with a receptor at the mammalian cell surface, triggering the intracellular mobilization of Ca 2+ [4] , an essential step for the trypanosome invasion. Deletion of the opdB gene in T. cruzi resulted in trypanosomes that were attenuated for virulence in a mouse model of infection [5] . In Trypanosoma brucei and Trypanosoma congolense, OpdB contributes to the pathogenesis of the infection through the anomalous degradation of biologically active peptides in the bloodstream of infected hosts [31] . Consistent with this view, the administration of irreversible OpdB inhibitors to trypanosomeinfected mice significantly impaired disease progression [19] . These results point out an important role of OpdB in the pathogenesis of parasitic diseases, and its potential as a novel target for antimicrobial therapy prompted an analysis of OpdB homologs in bacteria. Little is known about oligopeptidase B function in bacteria and no physiological substrates have been identified [6] . It has been previously observed that the OpdB from E. coli and Salmonella Typhimurium have a trypsin-like substrate specificity, cleaving peptides after basic residues of arginine and lysine [15, 16] , and its hydrolytic activity is restricted to peptides shorter than 30-40 residues [7] . In a previous work, OpdB was associated with resistance of E. coli cells to certain antimicrobial peptides (AMPs) [13] . These are an integral part of the innate immune system that Oligopeptidase B (OpdB) is a serine peptidase widespread among bacteria and protozoa that has emerged as a virulence factor despite its function has not yet been precisely established. By using an OpdB-overexpressing Escherichia coli strain, we found that the overexpressed peptidase makes the bacterial cells specifically less susceptible to several proline-rich antimicrobial peptides known to penetrate into the bacterial cytosol, and that its level of activity directly correlates with the degree of resistance. We established that E. coli OpdB can efficiently hydrolyze in vitro cationic antimicrobial peptides up to 30 residues in length, even though they contained several prolines, shortening them to inactive fragments. Two consecutive basic residues are a preferred cleavage site for the peptidase. In the case of a single basic residue, there is no cleavage if proline residues are present in the P 1 and P 2 positions. These results also indicate that cytosolic peptidases may cause resistance to antimicrobial peptides that have an intracellular mechanism of action, such as the proline-rich peptides, and may contribute to define the substrate specificity of the E. coli OpdB.
Keywords: Antimicrobial peptide, proline-rich, oligopeptidase B, proteolysis protect a host from invading pathogenic bacteria [20, 32] . AMPs are considered promising compounds for an alternative use in antibiotic therapy, and hence great effort is being done to understand their mechanism of action [12, 26] . AMPs generally act on the surface of the target cells and are membrane-permeabilizing agents. However, some of them penetrate into the cytoplasm and inhibit intracellular functions [3] . In a previous work, aimed to understand the mode of action of a class of antimicrobial peptides rich in proline residues (PR-AMPs), some E. coli clones showing a reduced susceptibility to the peptides Bac7(1-35) and Bac7(1-16) were isolated [13] . These clones were obtained by transformation of a wild-type strain with a genomic library constructed using DNA from a peptide-resistant mutant. Some plasmids conferring reduced sensitivity to the Bac7 peptides harbored a genomic region containing the opdB gene.
In this study, we investigated the relationship between expression of OpdB and decreased susceptibility of E. coli to proline-rich peptides in order to gain new insights on the activity of OpdB in terms of substrate specificity and mechanism of action. The peptidolytic activity of OpdB on AMPs suggests a possible involvement of this protein in bacterial pathogenicity and, at the same time, it may represent an interesting model to investigate the OpdB substrate specificity.
Materials and Methods

Peptides, Bacterial Strains, Media, and Growth Conditions
All AMPs used were synthesized, characterized, quantified, and stored as previously described [2] . Bacterial strains and plasmids used in this study are listed in Table 1 . Cultures were grown in Luria-Bertani (LB) or Mueller-Hinton (MH) broth at 37°C under aerobic conditions with the addition of antibiotics when required.
Antimicrobial Activity Assays
Determinations of the MIC (Minimum Inhibitory Concentration) values of the AMPs and of the bactericidal activity of Bac7(1-16) against E. coli strains were performed as previously described [2] . Significance of differences among groups was performed by the unpaired t test. Values of p < 0.05 were considered statistically significant.
Oligopeptidase B Cloning and Gene Deletion Constructs
The pBSAR-1 and pBSAR-11 clones derived from a Bac7-resistant mutant DNA library were prepared as previously described [13] . The opdB gene was amplified by PCR from the pBSAR-1 plasmid DNA using forward (5'-CGC AGA TCT ATG CTA CCA AAA GCC GC -3') and reverse (5'-ACA AGC TTA GTC CGC AGG CGT AGC -3') primers and cloned in the pQE-9 vector. In the resulting plasmid, pQAC-1, the OpdB ORF was fused with a His-tag sequence at the 5'-end, as confirmed by sequencing; this plasmid was then used to transform strain XL-1 Blue of E. coli. The pBSAR-1A, pBSAR-1B, and pBSAR-1C constructs were obtained by cleaving the pBSAR-1 plasmid respectively with BanII, NcoI, and SmaI, whereas the pBSAR-1D and pBSAR-1E constructs were obtained by cutting pBSAR-1 and pBSAR-11 with BamHI/HindIII.
Expression and Purification of Recombinant Oligopeptidase B
A strain expressing oligopeptidase B (HB3P) was obtained by co-transformation of HB101 with the pQAC-1 and pREP4 plasmids. Mid-logarithmic phase HB3P cultures were incubated in LB broth b Keio Collection at GenoBase (http://ecoli.aist-nara.ac.jp).
